Exosomes are tiny bubble-like particles, typically 30 to 150 nanometers in diameter, that your cells naturally release to communicate with other cells throughout your body. To put that size in perspective, you could line up roughly 500 exosomes across the width of a single human hair. Despite being incredibly small, these particles carry a cargo of proteins, genetic material, fats, and metabolites that can change the behavior of whatever cell receives them. They’ve become one of the most closely watched topics in medicine because of their potential roles in diagnostics, drug delivery, and understanding how diseases spread.
How Your Cells Make and Release Exosomes
Exosomes don’t simply pinch off from the outer surface of a cell. They form through a more complex internal process. It starts when a section of a cell’s inner compartment (called an endosome) folds inward and creates small bubbles inside itself. This creates a structure packed with tiny internal vesicles, known as a multivesicular body. Think of it like a water balloon filled with dozens of smaller water balloons.
When that larger structure moves to the cell’s outer membrane and fuses with it, all those small internal bubbles spill out into the space between cells. Those released bubbles are exosomes. A wide variety of cells produce them, including neurons, immune cells, skin cells, and tumor cells. The cargo packed inside reflects the identity and current state of the cell that made them, which is why exosomes from a cancer cell carry different molecular signatures than those from a healthy cell.
How Exosomes Differ From Other Cell Particles
Your cells release several types of particles, and exosomes are the smallest. Microvesicles, which bud directly off the cell’s outer membrane rather than forming internally, range from 100 to 1,000 nanometers. Apoptotic bodies, released when a cell dies through programmed self-destruction, are much larger still, spanning 1,000 to 5,000 nanometers, and they can contain fragments of the cell’s internal machinery, including pieces of its DNA and even organelles.
Beyond size, the key distinction is origin. Exosomes are built inside the cell and sorted through a regulated packaging process. Microvesicles form in seconds as the outer membrane blebs outward. Exosome formation takes ten minutes or more. Exosome membranes are also enriched in cholesterol and ceramide, giving them a stable, raft-like structure that helps them survive the journey between cells.
What Exosomes Do in the Body
The core function of exosomes is intercellular communication. When an exosome reaches a recipient cell, it can fuse with that cell’s membrane or be taken up into it, delivering its cargo of proteins, small RNA molecules, lipids, and metabolites. This delivery can alter how the recipient cell behaves, changing which genes it activates or suppresses, how quickly it grows, or how it responds to threats. These effects can be beneficial or harmful depending on context.
In healthy tissue, exosomes help coordinate immune responses, support tissue repair, and maintain normal cell function. In disease, the picture shifts. Tumor cells, for example, release exosomes that can prepare distant tissues for metastasis or suppress the immune system’s ability to fight the cancer. This dual nature, both disease-promoting and disease-restraining, is what makes exosomes so scientifically interesting.
Exosomes as Diagnostic Tools
Because exosomes circulate in blood, urine, saliva, and other body fluids, and because their cargo mirrors the cell that produced them, researchers are developing “liquid biopsy” approaches that analyze exosomes to detect disease early. The idea is straightforward: instead of surgically removing a tissue sample, a simple blood draw could reveal the molecular fingerprints of a tumor or other condition.
This approach is furthest along in cancer detection. Specific small RNA molecules carried inside exosomes have shown promise in distinguishing early-stage breast cancer from advanced cases. In lung cancer, certain exosomal RNA signatures are being evaluated for diagnostic value. Prostate and colorectal cancers are also active areas of investigation. None of these tests have replaced standard screening methods yet, but the goal is a less invasive, more accessible way to catch cancers earlier.
Drug Delivery Potential
One of the most exciting applications involves loading exosomes with therapeutic drugs and using them as delivery vehicles. Synthetic nanoparticles, the current standard for targeted drug delivery, come with drawbacks: they can trigger immune reactions, carry some toxicity, and require complex manufacturing. Exosomes sidestep several of these problems. Because they’re naturally produced by cells, the body is less likely to flag them as foreign invaders. They’re stable enough to travel long distances through the bloodstream, they can penetrate deep into tissues, and, notably, they can cross the blood-brain barrier, a significant hurdle for treating neurological conditions.
Researchers have successfully loaded exosomes with chemotherapy agents, gene-silencing molecules, and immune-modulating compounds in laboratory and animal studies. The ability to engineer their surface so they home in on specific cell types adds another layer of precision. This work is still largely preclinical, but it represents a fundamentally different approach to getting drugs where they need to go.
Plant-Derived Exosome-Like Particles
Plants also release nanovesicles with a structure similar to animal exosomes. These plant-derived particles have shown anti-inflammatory and anti-tumor properties in early research, and they carry active lipids, proteins, and nucleic acids much like their mammalian counterparts. One practical advantage is safety: because they come from edible plants, they’re less likely to trigger an immune response or carry animal pathogens. They can potentially be taken orally and still reach their targets, which would simplify drug delivery considerably.
Plant-derived nanovesicles are also cheaper and easier to produce at scale than animal-derived exosomes. Research has found they share many of the same benefits as animal-sourced exosomes, including the ability to cross the blood-brain barrier, while adding specific pharmacological effects tied to their plant of origin. This is a newer area of study, but it’s expanding quickly because of the production and safety advantages.
Exosomes in Skin Health and Aging
Stem cell-derived exosomes have generated significant interest in dermatology. In laboratory studies, these exosomes boosted collagen and elastin production in skin cells, reduced the activity of enzymes that break down the skin’s structural matrix, and accelerated wound healing. Exosomes derived from umbilical cord blood stem cells, which contain high concentrations of growth factors, increased both collagen output and the migration ability of skin fibroblasts, the cells responsible for producing the skin’s connective tissue.
In aged mice, specific RNA molecules delivered via exosomes reduced cellular aging markers in skin cells and promoted wound repair. These findings have fueled a wave of exosome-containing skincare products and cosmetic treatments. However, the gap between controlled laboratory results and what a consumer product delivers to your skin is substantial, and no exosome-based cosmetic treatment has undergone the kind of rigorous clinical testing required for medical claims.
No Exosome Therapies Are FDA-Approved
This is the single most important thing to know if you’re considering any exosome-based treatment: there are currently no FDA-approved exosome products. The FDA has issued a consumer alert warning that many clinics market exosome treatments illegally, without evidence that they are safe or effective. These products require FDA approval before they can be legally sold for treating diseases or medical conditions.
The FDA’s warning covers a broad range of claims. No exosome product has been approved for orthopedic conditions like osteoarthritis, back pain, or tendonitis. None have been approved for neurological disorders including Alzheimer’s, Parkinson’s, ALS, or multiple sclerosis. None are approved for heart disease, lung disease, chronic pain, autism, macular degeneration, or fatigue. And none were ever approved for treating or preventing COVID-19. Clinics offering these treatments are operating outside regulatory approval, and patients have reported adverse effects. The science behind exosomes is genuinely promising, but the commercial market has raced far ahead of the evidence.